Zambon Company - M&A Summary and Business Overview

Life ScienceCompany

Zambon Company M&A Summary

Zambon Company has acquired 1 company, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Zambon Company’s largest acquisition to date was in 2019, when it acquired Breath Therapeutics for $158M. The Company’s most targeted sectors include life science (100%).

Zambon Company Business Overview

Where is Zambon Company headquartered?

Zambon Company is headquartered in Bresso, Italy.

What sector is Zambon Company in?

Zambon Company is a life science company.

When was Zambon Company founded?

Zambon Company was founded in 1906.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity1
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 4

Zambon Company S.p.A.

Via Lillo del Duca, 10,
Bresso, 20091
Italy,
+39 02 665241
www.zambongroup.com

Zambon Company S.p.A. is a multicultural group with close links to its local markets and the international research community. Zambon a pharmaceutical and chemical multinational with a reputation for inventive and innovative thinking, flexibility and customer focus.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $158M $158M
Sell (0.2/yr) # 1 - - 1 - - 2
  3

Most Recent M&A

Company Date Value Type
Axxam S.p.A. 2022-07-28 - Divestiture
Bresso, Italy · www.axxam.com
Breath Therapeutics 2019-07-25 158M EUR Add-on Acquisition
Munich, Germany · www.breath-therapeutics.com
Topgen, E.S.V. 2007-11-15 - Divestiture
Brussels, Belgium
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 158M (100%) 2 (100%) -
Total 1 $158M 2 -

By Geo

State/Country Buy Value Sell Value
Belgium - - 1 -
Germany 1 158M - -
Italy - - 1 -
Domestic - - 1 (50%) -
Cross-border 1 (100%) 158M (100%) 1 (50%) -
Total 1 $158M 2 -

Deal Values

buy # Total
$100M to $1B 1 $158M
TOTAL $158M
Largest Breath Therapeutics
$158M (2019-07-25)

M&A Connections

Deals
Acquired from
Investor(s)
100%
1 (100%)
Divested to
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Zambon Company

Life Science Companies , Italy Companies